Eris Lifesciences Limited — Board Meeting, 29-07-2026: Outcome of Board Meeting
29-07-2026 | 01:10 pm
29-07-2026 | 01:10 pm
Eris Lifesciences announced its board approved the Q1 FY27 consolidated financial results. Net Profit stood at Rs 143.32 Cr and Revenue at Rs 873.25 Cr for the quarter. The Board also re-appointed M/s Kiran J. Mehta & Co. as Cost Auditors for FY27.
No comments yet. Be the first to comment!
